Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Shire LLC v. Amerigan Pharms. Ltd., 14-6095 (D.N.J.) Oct. 1, 2014 Hon. Renee Marie Bumb Adderall XR® (dextroamphetamine sulfate / dextroamphetamine saccharate /
amphetamine aspartate monohydrate / amphetamine sulfate tablets)
RE42,096
RE41,148
Supernus Pharms., Inc. v. Actavis, Inc., 14-6102 (D.N.J.) Oct. 1, 2014 Hon. Susan D. Wigenton Trokendi XR® (topiramate extended-release capsules) 8,298,576
8,298,580
8,663,683
Kowa Co., Ltd. v. Apotex, Inc., 14-7934 (S.D.N.Y.) Oct. 1, 2014 Hon. Paul A. Crotty Livalo® (pitavastatin calcium tablets) 8,557,993
Sandoz Inc. v. EKR Therapeutics, LLC, IPR2015-00005 (PTAB) Oct. 1, 2014 N/A Cardene® (nicardipine hydrochloride) 8,455,524
Sandoz Inc. v. EKR Therapeutics, LLC, IPR2015-00006 (PTAB) Oct. 1, 2014 N/A Cardene® (nicardipine hydrochloride) 7,612,102
Sandoz Inc. v. EKR Therapeutics, LLC, IPR2015-00007 (PTAB) Oct. 1, 2014 N/A Cardene® (nicardipine hydrochloride) 7,659,290
Sandoz Inc. v. EKR Therapeutics, LLC, IPR2015-00008 (PTAB) Oct. 1, 2014 N/A Cardene® (nicardipine hydrochloride) 7,659,291
Kowa Co., Ltd. v. Apotex, Inc., 14-1264 (D. Del.) Oct. 2, 2014 Hon. Sue L. Robinson Livalo® (pitavastatin calcium tablets) 8,557,993
Forest Labs., LLC v. Hikma Pharms., LLC, 14-1266 (D. Del.) Oct. 2, 2014 Hon. Sue L. Robinson Saphris® (asenapine maleate tablets) 8,022,228
7,741,358
Jazz Pharms., Inc. v. Par Pharm., Inc., 14-6150 (D.N.J.) Oct. 2, 2014 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,772,306
Jazz Pharms., Inc. v. Ranbaxy Labs., Ltd., 14-6151 (D.N.J.) Oct. 2, 2014 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,772,306
Otsuka Pharm. Co., Ltd. v. Intas Pharms. Ltd., 14-6158 (D.N.J.) Oct. 2, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,759,350
Forest Labs, LLC v. Amerigan Pharms., Inc., 14-1271 (D. Del.) Oct. 3, 2014 Hon. Leonard P. Stark Namenda XR® (memantine hydrochloride
extended-release capsules)
8,039,009
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233
Teva Pharms. USA, Inc. v. Mylan Pharms. Inc., 14-1278 (D. Del.) Oct. 6, 2014 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate for injection) 8,232,250
8,399,413
Otsuka Pharm. Co., Ltd. v. Sun Pharm. Industries Ltd., 14-6397 (D.N.J.) Oct. 6, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,759,350
Teva Pharms. USA, Inc. v. Mylan Pharms. Inc., 14-0167 (N.D.W.V.) Oct. 7, 2014 Hon. Irene M. Keeley Copaxone® (glatiramer acetate for injection) 8,232,250
8,399,413
Novartis Pharms. Corp. v. Dr. Reddy’s Labs., Ltd., 14-1283 (D. Del.) Oct. 8, 2014 Hon. Leonard P. Stark Gleevec® (imatinib mesylate capsules) 6,894,051
RE43,932
Eli Lilly and Co. v. Nang Kuang Pharm. Co., Ltd., 14-1647 (S.D. Ind.) Oct. 8, 2014 Hon. Jane Magnus-Stinson Alimta® (pemetrexed disodium for intravenous infusion) 5,344,932
7,772,209
AbbVie Inc. v. Mylan Pharms. Inc., 14-1288 (D. Del.) Oct. 9, 2014 Hon. Richard G. Andrews Norvir® (ritonavir tablets) 7,148,359
7,364,752
Novartis Pharms. Corp. v. Dr. Reddy’s Labs., Ltd., 14-6280 (D.N.J.) Oct. 9, 2014 Hon. Claire C. Cecchi Gleevec® (imatinib mesylate capsules) 6,894,051
RE43,932
Braintree Labs., Inc. v. Taro Pharms. USA, Inc., 14-8147 (S.D.N.Y.) Oct. 9, 2014 Hon. Alison J. Nathan Suprep® (sodium sulfate, potassium sulfate, magnesium sulfate oral solution) 6,946,149
Novartis Pharms. Corp. v. Par Pharm., Inc., 14-1289 (D. Del.) Oct. 10, 2014 Hon. Richard G. Andrews Zortress® (everolimus tablets) 5,665,772
6,004,973
6,455,518
Otsuka Pharm. Co., Ltd. v. Amneal Pharms., LLC, 14-6340 (D.N.J.) Oct. 10, 2014 Hon. Mary L. Cooper Abilify® (aripiprazole oral solution) 8,759,350
Otsuka Pharm. Co., Ltd. v. Teva Pharms. USA, Inc., 14-6398 (D.N.J.) Oct. 10, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,580,796
8,642,760
Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc., 14-6341 (D.N.J.) Oct. 13, 2014 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride IV solutions) 8,729,094
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 14-1309 (D. Del.) Oct. 15, 2014 Hon. Gregory M. Sleet Quillivant XR® (methylphenidate hydrochloride extended-release oral suspension) 8,465,765
8,563,033
8,778,390
Noven Therapeutics, LLC v. Actavis Labs. FL, Inc., 14-6414 (D.N.J.) Oct. 16, 2014 Hon. Faith S. Hochberg Brisdelle® (paroxetine mesylate capsule) 5,874,447
7,598,271
8,658,663
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 14-6425 (D.N.J.) Oct. 16, 2014 Hon. Stanley R. Chesler Quillivant XR® (methylphenidate hydrochloride extended-release oral suspension) 8,465,765
8,563,033
8,778,390
Cephalon, Inc. v. Wockhardt Bio Ltd., 14-1332 (D. Del.) Oct. 21, 2014 Hon. Gregory M. Sleet Treanda® (bendamustine hydrochloride for infusion) 8,445,524
8,436,190
8,609,863
8,791,270
AstraZeneca Pharms. LP v. Pharmadax USA, Inc., 14-6557 (D.N.J.) Oct. 22, 2014 Hon. Noel L. Hillman Seroquel® XR (quetiapine fumarate extended-release tablets) 5,948,437
AstraZeneca Pharms. LP v. Pharmadax USA, Inc., 14-1710 (C.D. Cal.) Oct. 23, 2014 Hon. James V. Selna Seroquel® XR (quetiapine fumarate extended-release tablets) 5,948,437
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00131 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 6,468,967
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00132 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 6,852,689
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00140 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 8,129,342
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00141 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 8,058,238
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00142 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 8,058,238
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00143 (PTAB) Oct. 23, 2014 N/A Cubicin® (daptomycin for injection) 8,058,238
Agila Specialties Inc. v. Cubist Pharms., Inc., IPR2015-00144 (PTAB) Oct. 24, 2014 N/A Cubicin® (daptomycin for injection) 8,058,238
Otsuka Pharm. Co., Ltd. v. Apotex Corp., 14-6707 (D.N.J.) Oct. 27, 2014 Hon. Mary L. Cooper Abilify® (aripiprazole oral solution) 7,053,092
8,642,600
8,759,350
AstraZeneca AB v. Actavis Labs. FL, Inc., 14-1356 (D. Del.) Oct. 31, 2014 Hon. Gregory M. Sleet Kombiglyze® XR (saxagliptin hydrochloride / metformin hydrochloride tablets) RE44,186
8,628,799
Otsuka Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 14-6890 (D.N.J.) Oct. 31, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,759,350
Daravita Ltd. v. Alvogen Pine Brook, Inc., 14-1364 (D. Del.) Nov. 3, 2014 Hon. Gregory M. Sleet Zohydro ER® (hydrocodone bitartrate extended-release capsules) 6,228,398
6,902,742
Senju Pharm. Co., Ltd. v. Innopharma Licensing, Inc., 14-6893 (D.N.J.) Nov. 3, 2014 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution) 8,129,431
8,669,290
8,754,131
8,871,813
Otsuka Pharm. Co., Ltd. v. Lupin Ltd., 14-7105 (D.N.J.) Nov. 3, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,017,615
8,580,796
8,642,760
8,759,350
Fresenius-Kabi USA LLC v. Cubist Pharms., Inc., IPR2015-00223 (PTAB) Nov. 3, 2014 N/A Cubicin® (daptomycin for injection) 6,852,689
Fresenius-Kabi USA LLC v. Cubist Pharms., Inc., IPR2015-00227 (PTAB) Nov. 3, 2014 N/A Cubicin® (daptomycin for injection) 6,468,967
Teijin Ltd. v. Unimark Remedies, Ltd., 14-1370 (D. Del.) Nov. 4, 2014 Hon. Sue L. Robinson Uloric® (febuxostat tablets) 7,361,676
Endo Pharms. Inc. v. Actavis Inc., 14-1381 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Amneal Pharms., LLC, 14-1382 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Impax Labs., Inc., 14-1383 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Impax Labs., Inc., 14-1384 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Par Pharm. Companies, Inc., 14-1385 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Ranbaxy Labs. Ltd., 14-1386 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Roxane Labs., Inc., 14-1387 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Sandoz, Inc., 14-1388 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
Endo Pharms. Inc. v. Teva Pharms. USA, Inc., 14-1389 (D. Del.) Nov. 7, 2014 Hon. Richard G. Andrews Opana ER® (oxymorphone hydrochloride extended-release tablets) 8,808,737
8,871,779
AstraZeneca Pharms. LP v. Pharmadax USA, Inc., 14-7007 (D.N.J.) Nov. 7, 2014 Hon. Noel L. Hillman Seroquel® XR (quetiapine fumarate extended-release tablets) 5,948,437
Shire Development Natco Pharma Ltd., 14-7053 (D.N.J.) Nov. 10, 2014 Hon. Stanley R. Chesler Fosrenol® (lanthanum carbonate chewable tablets) 5,968,976
7,381,428
7,465,465
Otsuka Pharm. Co., Ltd. v. Actavis Elizabeth LLC, 14-7106 (D.N.J.) Nov. 10, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,580,796
8,642,760
8,759,350
Pfizer Inc. v. Tiger Pharms., LLC, 14-1501 (E.D. Va.) Nov. 10, 2014 Hon. Anthony J. Trenga Tikosyn® (dofetilide capsules) 6,124,363
Pfizer Inc. v. Tiger Pharms., LLC, 14-8958 (S.D.N.Y.) Nov. 10, 2014 Hon. Gregory H. Woods Tikosyn® (dofetilide capsules) 6,124,363
Baxter Healthcare Corp. v. Agila Specialties Private Ltd., 14-7094 (D.N.J.) Nov. 12, 2014 Hon. Faith S. Hochberg Brevibloc® (esmolol hydrochloride in sodium chloride solution) 6,310,094
6,528,540
Sucampo AG v. Dr. Reddy’s Labs., Inc., 14-7114 (D.N.J.) Nov. 12, 2014 Hon. Michael A. Shipp Amitiza® (lubiprostone capsules) 6,414,016
8,071,613
7,795,312
8,097,653
8,389,542
8,026,393
8,338,639
Mylan Pharms. Inc. v. Novartis AG, IPR2015-00265 (PTAB) Nov. 13, 2014 N/A Exelon® Patch (rivastigmine transdermal system or extended-release film) 6,316,023
Mylan Pharms. Inc. v. Novartis AG, IPR2015-00268 (PTAB) Nov. 13, 2014 N/A Exelon® Patch (rivastigmine transdermal system or extended-release film) 6,335,031
Baxter Healthcare Corp. v. Agila Specialties Private Ltd., 14-0190 (N.D.W.V.) Nov. 13, 2014 Hon. Irene M. Keeley Brevibloc® (esmolol hydrochloride in sodium chloride solution) 6,310,094
6,528,540
Purdue Pharma L.P. v. Watson Labs., Inc., 14-1410 (D. Del.) Nov. 14, 2014 Hon. Sue L. Robinson Butrans® (buprenorphine transdermal system) RE41,408
RE41,489
RE41,571
BioMarin Pharm. Inc. v. Dr. Reddy’s Labs., Inc., 14-7203 (D.N.J.) Nov. 17, 2014 Hon. Michael A. Shipp Kuvan® (sapropterin dihydrochloride tablets) 7,566,462
7,566,714
7,612,073
8,003,126
8,067,416
RE43,797
8,318,745
Teva Pharms. USA, Inc. v. Synthon Pharms. Inc., 14-1419 (D. Del.) Nov. 18, 2014 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate for injection) 8,232,250
8,399,413
Teva Pharms. USA, Inc. v. Synthon Pharms. Inc., 14-0975 (D. Del.) Nov. 19, 2014 Hon. Catherine C. Eagles Copaxone® (glatiramer acetate for injection) 8,232,250
8,399,413
Par Pharm., Inc. v. GlaxoSmithKline LLC, 14-6627 (E.D. Pa.) Nov. 19, 2014 Hon. Nitza I. Quinones Alejandro Lamictal ODT® (lamotrigine tablets) 7,919,115
Endo Pharms. Solutions Inc. v. Paddock Labs., LLC, 14-1422 (D. Del.) Nov. 20, 2014 Hon. Sue L. Robinson Aveed® (testosterone undecanoate for injection) 7,718,640
8,338,395
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 14-7252 (D.N.J.) Nov. 20, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,017,615
8,580,796
8,642,760
AstraZeneca AB v. Actavis Labs. FL, Inc., 14-7263 (D.N.J.) Nov. 20, 2014 Hon. Mary L. Cooper Nexium 24HR® (esomeprazole magnesium delayed-release capsules) 6,369,085
7,411,070
Supernus Pharms., Inc. v. Zydus Pharms. (USA) Inc., 14-7272 (D.N.J.) Nov. 21, 2014 Hon. Susan D. Wigenton Trokendi XR® (topiramate extended-release capsules) 8,298,576
8,298,580
8,663,683
Sanofi v. Sandoz Inc., 14-1434 (D. Del.) Nov. 24, 2014 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 8,318,800
8,410,167
8,602,215
Fresenius Kabi USA, LLC v. Agila Specialties Private Ltd., 14-1438 (D. Del.) Nov. 26, 2014 Hon. Richard G. Andrews Diprivan® (propofol injectable) 8,476,010
Fresenius Kabi USA, LLC v. Agila Specialties Private Ltd., 14-0205 (N.D.W.V.) Nov. 26, 2014 Hon. Irene M. Keeley Diprivan® (propofol injectable) 8,476,010
Noven Therapeutics, LLC v. Prinston Pharm. Inc., 14-7400 (D.N.J.) Nov. 26, 2014 Hon. Faith S. Hochberg Brisdelle® (paroxetine mesylate capsule) 5,874,447
7,598,271
8,658,663
Otsuka Pharm. Co., Ltd. v. Alembic Pharms. Ltd., 14-7405 (D.N.J.) Nov. 26, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,759,350
Bausch & Lomb Inc. v. Micro Labs USA, Inc., 14-7406 (D.N.J.) Nov. 26, 2014 Hon. Noel L. Hillman Bepreve® (bepotastine besilate ophthalmic solution) 8,784,789
Reckitt Benckiser Pharms. Inc. v. Teva Pharms. USA, Inc., 14-1451 (D. Del.) Dec. 2, 2014 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,475,832
8,017,150
8,603,514
Meda Pharms. Inc. v. Apotex Inc., 14-1453 (D. Del.) Dec. 2, 2014 Hon. Leonard P. Stark Dymista® (azelastine hydrochloride / fluticasone propionate nasal spray) 8,163,723
8,168,620
Novartis Pharms. Corp. v. Amneal Pharms., LLC, 14-7557 (D.N.J.) Dec. 3, 2014 Hon. Susan D. Wigenton Zometa® (zoledronic acid for injection) 8,324,189
Novartis Pharms. Corp. v. Par Sterile Products, LLC, 14-7558 (D.N.J.) Dec. 3, 2014 Hon. Susan D. Wigenton Zometa® / Reclast® (zoledronic acid for injection) 7,932,241
8,052,987
8,324,189
Allergan, Inc. v. Wilshire Pharms., Inc., 14-1461 (D. Del.) Dec. 4, 2014 Hon. Leonard P. Stark Lastacaft® (alcaftadine ophthalmic solution) 8,664,215
Eli Lilly and Co. v. Sandoz Inc., 14-2008 (S.D. Ind.) Dec. 5, 2014 Hon. Tanya Walton Pratt Alimta® (pemetrexed disodium for injection) 7,772,209
Fresenius Medical Care Holdings, Inc. v. Lotus Pharms. Co., Ltd., 14-14345 (D. Mass.) Dec. 5, 2014 Hon. Richard G. Stearns PhosLo® GelCaps (calcium acetate) 6,576,665
Fresenius Medical Care Holdings, Inc. v. Lotus Pharms. Co., Ltd., 14-7612 (D.N.J.) Dec. 5, 2014 Hon. Stanley R. Chesler PhosLo® GelCaps (calcium acetate) 6,576,665
Teva Women’s Health, Inc. v. Famy Care Ltd., 14-9637 (S.D.N.Y.) Dec. 5, 2014 Hon. Shira A. Scheindlin Quartette® (levonorgestrel / ethinyl estradiol and ethinyl estradiol tablets) 8,415,332
8,450,299
AstraZeneca AB v. Aurobindo Pharma Ltd., 14-1469 (D. Del.) Dec. 9, 2014 Hon. Gregory M. Sleet Onglyza® (saxagliptin hydrochloride tablets) RE44,186
Duke University v. Apotex, Inc., 14-1028 (M.D.N.C) Dec. 9, 2014 Hon. Catherine C. Eagles Latisse® (bimatoprost topical solution) 8,906,962
Eli Lilly and Co. v. Amneal Pharms. LLC, 14-2025 (S.D. Ind.) Dec. 10, 2014 Hon. Sarah Evans Barker Axiron® (testosterone metered transdermal solution) 8,435,449
8,419,307
8,177,409
8,807,861
Duke University v. Sandoz, Inc., 14-1034 (M.D.N.C.) Dec. 10, 2014 Hon. Catherine C. Eagles Latisse® (bimatoprost topical solution) 8,906,962
Lupin Ltd. v. ViiV Healthcare Co., IPR2015-00405 (PTAB) Dec. 10, 2014 N/A Lexiva® (fosamprenavir calcium) 6,436,989
Eli Lilly and Co. v. Amneal Pharms. LLC, 14-1474 (D. Del.) Dec. 11, 2014 Hon. Sue L. Robinson Axiron® (testosterone metered transdermal solution) 8,435,449
8,419,307
8,177,409
8,807,861
Jazz Pharms., Inc. v. Watson Labs., Inc., 14-7757 (D. Del.) Dec. 11, 2014 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 6,472,431
6,780,889
7,262,219
7,851,506
8,263,650
8,324,275
8,461,203
7,668,730
7,765,106
7,765,107
7,895,059
8,457,988
8,589,182
8,731,963
8,772,306
Apotex Inc. v. Merck and Co., Inc., IPR2015-00419 (PTAB) Dec. 11, 2014 N/A Emend® (fosaprepitant dimeglumine) 5,691,336
AstraZeneca Pharms. LP v. Teva Pharms. USA, Inc., 14-1478 (D. Del.) Dec. 12, 2014 Hon. Gregory M. Sleet Byetta® (exenatide injection) 6,858,576
6,872,700
6,956,026
7,297,761
6,902,744
7,521,423
7,741,269
Shire Development LLC v. Invagen Pharms., Inc., 14-7263 (E.D.N.Y.) Dec. 12, 2014 Hon. Brian M. Cogan Fosrenol® (lanthanum carbonate chewable tablets) 5,968,976
7,381,428
7,465,465
Boehringer Ingelheim Pharma Gmbh v. Teva Pharms. USA, Inc., 14-7811 (D.N.J.) Dec. 15, 2014 Hon. Mary L. Cooper Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Novartis AG v. Actavis, Inc., 14-1487 (D. Del.) Dec. 16, 2014 Hon. Leonard P. Stark Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Novartis AG v. Actavis, Inc., 14-7849 (D.N.J.) Dec. 17, 2014 Hon. Madeline C. Arleo Gilenya® (fingolimod hydrochloride capsules) 5,604,229
AstraZeneca AB v. Actavis Labs. FL, Inc., 14-7870 (D.N.J.) Dec. 17, 2014 Hon. Joel A. Pisano Nexium® (esomeprazole magnesium delayed-release capsules) 5,714,504
6,369,085
7,411,070
8,466,175
Novartis Pharms. Corp. v. Par Pharm., Inc., 14-1494 (D. Del.) Dec. 18, 2014 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 5,665,772
7,297,703
7,741,338
Ranbaxy Labs. Ltd v. Adamas Pharms., Inc., IPR2015-00410 (PTAB) Dec. 18, 2014 N/A Namenda XR® (memantine hydrochloride extended-release capsules) 8,362,085
Fresenius Kabi USA, LLC v. Claris Lifesciences Ltd., 14-1498 (D. Del.) Dec. 19, 2014 Hon. Richard G. Andrews Diprivan® (propofol injectable) 8,476,010
Cadence Pharms., Inc. v. Agila Specialties Private Ltd., Inc., 14-1499 (D. Del.) Dec. 19, 2014 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 6,028,222
6,992,218
Fresenius Kabi USA, LLC v. Claris Lifesciences Ltd., 14-7953 (D.N.J.) Dec. 19, 2014 Hon. Noel L. Hillman Diprivan® (propofol injectable) 8,476,010
Forest Labs., LLC v. Breckenridge Pharm., Inc., 14-1504 (D. Del.) Dec. 22, 2014 Hon. Sue L. Robinson Saphris® (asenapine maleate tablets) 5,763,476
8,022,228
7,741,358
Otsuka Pharm. Co., Ltd. v. Sciegen Pharms. Inc., 14-8077 (D.N.J.) Dec. 22, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,017,615
8,580,796
8,642,760
Novartis Pharms. Corp. v. Roxane Labs., Inc., 14-1508 (D. Del.) Dec. 23, 2014 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 5,665,772
7,297,703
7,741,338
Eisai Co., Ltd. v. Roxane Labs., Inc., 14-1511 (D. Del.) Dec. 23, 2014 Hon. Leonard P. Stark Banzel® (rufinamide oral suspension) 6,740,669
7,750,028
Iceutica Pty Ltd. v. Lupin Ltd., 14-1515 (D. Del.) Dec. 23, 2014 Hon. Sue L. Robinson Zorvolex® (diclofenac capsules) 8,679,544
Cadence Pharms., Inc. v. Agila Specialties Private Ltd., Inc., 14-8000 (D.N.J.) Dec. 23, 2014 Hon. Renee Marie Bumb Ofirmev® (acetaminophen for injection) 6,028,222
6,992,218
AstraZeneca AB v. Andrx Labs, 14-8030 (D.N.J.) Dec. 24, 2014 Hon. Joel A. Pisano Nexium 24HR® (esomeprazole magnesium delayed-release capsules) 6,369,085
7,411,070
Otsuka Pharm. Co., Ltd. v. Apotex Corp., 14-8074 (D.N.J.) Dec. 24, 2014 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 8,017,615
8,580,796
8,642,760
8,759,350
Agila Specialties Inc. v. Cephalon, Inc., IPR2015-00503 (PTAB) Dec. 24, 2014 N/A Treanda® (bendamustine hydrochloride for infusion) 8,436,190
Novartis Pharms. Corp. v. Ranbaxy Inc., 14-1526 (D. Del.) Dec. 29, 2014 Hon. Leonard P. Stark Gleevec® (imatinib mesylate capsules) 6,894,051
RE43,932
Sanofi-Aventis U.S. LLC v. Accord Healthcare, Inc., 14-8079 (D.N.J.) Dec. 29, 2014 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 5,847,170
Sanofi-Aventis U.S. LLC v. BPI Labs, LLC, 14-8081 (D.N.J.) Dec. 29, 2014 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 5,847,170
Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC, 14-8082 (D.N.J.) Dec. 29, 2014 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 5,847,170
Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC, 14-1533 (D. Del.) Dec. 30, 2014 Hon. Leonard P. Stark Jevtana® Kit (cabazitaxel injection) 5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. BPI Labs, LLC, 14-3233 (M.D. Fla.) Dec. 30, 2014 Hon. Elizabeth A. Kovachevich Jevtana® Kit (cabazitaxel injection) 5,847,170
Reckitt Benckiser Pharms. Inc. v. Par Pharma., Inc., 14-1573 (D. Del.) Dec. 31, 2014 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,900,497
8,906,277
Reckitt Benckiser Pharms. Inc. v. Watson Labs., Inc., 14-1574 (D. Del.) Dec. 31, 2014 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,900,497
8,906,277
Apotex, Inc. v. Novartis AG, IPR2015-00518 (PTAB) Dec. 31, 2014 N/A Gilenya® (fingolimod capsules) 8,324,283

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.